In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod

We evaluated the in silico expression and circulating levels of interleukin (IL)37 in patients with different forms of multiple sclerosis (MS) and also upon treatment with different disease-modifying drugs. The combined interpretation of the resulting data strengthens and extends the current emergin...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Molecules
Auteurs principaux: Cavalli, Eugenio, Mazzon, Emanuela, Basile, Maria Sofia, Mammana, Santa, Pennisi, Manuela, Fagone, Paolo, Kalfin, Reni, Martinovic, Vanja, Ivanovic, Jovana, Andabaka, Marko, Mesaros, Sarlota, Pekmezovic, Tatjana, Drulovic, Jelena, Nicoletti, Ferdinando, Petralia, Maria Cristina
Format: Artigo
Langue:Inglês
Publié: MDPI 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6982851/
https://ncbi.nlm.nih.gov/pubmed/31861585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules25010020
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires